XML 44 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Liabilities Measured on Recurring Basis
The following tables present the Company's financial assets and liabilities that are measured at estimated fair value on a recurring basis as of March 31, 2026, and December 31, 2025:
Fair value measurements as of March 31, 2026
(in thousands)
Carrying valueLevel 1Level 2Level 3
Financial assets:
Cash equivalents:
Money market funds3,186 3,186 — — 
Total$3,186 $3,186 $ $ 
Liabilities:
Contingent consideration1,310 — — 1,310 
Total
$1,310 $ $ $1,310 
Fair value measurements as of December 31, 2025
(in thousands)
Carrying valueLevel 1Level 2Level 3
Financial assets:
Cash equivalents:
Money market funds161 161 — — 
Total161 161 — — 
Available-for-sale marketable securities:
U.S. government agencies securities1,018 — 1,018 — 
Total1,018 — 1,018 — 
Total$1,179 $161 $1,018 $ 
Liabilities:
Contingent consideration1,741 — — 1,741 
Total
$1,741 $ $ $1,741 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following is a reconciliation of changes in the liability related to contingent consideration during the three months ended March 31, 2026:

Three Months Ended March 31,
2026
(in thousands)
Fair value as of January 1,
$1,741 
Change in fair value76 
Earn-out payments in cash(43)
Earn-out payments in shares of common stock(464)
Fair value as of March 31, $1,310